[Evaluation of amikacin in obstetric and gynecological fields (author's transl)].
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D000653:Amniotic Fluid / Q000032:analysis; D001424:Bacterial Infections / Q000188:drug therapy; D001472:Bartholin's Glands; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D008413:Mastitis / Q000188:drug therapy; D008431:Maternal-Fetal Exchange; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008895:Milk, Human / Q000032:analysis; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011247:Pregnancy; D011549:Pseudomonas / Q000187:drug effects; D011645:Puerperal Infection / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013530:Surgical Wound Infection / Q000188:drug therapy; D014470:Umbilical Cord / Q000032:analysis; D014552:Urinary Tract Infections / Q000188:drug therapy; D014591:Uterine Diseases / Q000188:drug therapy
D000613:Aminobutyrates; D007612:Kanamycin